Global Market Access for Pharma & MedTech
Mtech Access (Petauri Evidence) (mtechaccess.co.uk) scores 75 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Marketing & Advertising brands, Other brands, in the 49th percentile of 21744 Healthcare brands.
Mtech Access, operating under Petauri Evidence, is a specialist pharmaceutical and medtech consultancy focused on market access, pricing, and health economics and outcomes research (HEOR). The company supports pharmaceutical, biotechnology, and medical device clients in generating, applying, and communicating evidence to inform healthcare decision-making. It combines traditional consultancy services with digital solutions and holds full Veeva Content Partner status, positioning itself as a strategic partner across the product lifecycle for teams seeking reimbursement success and market access milestones.
| Brand Name | Mtech Access (Petauri Evidence) |
|---|---|
| Domain | mtechaccess.co.uk |
| Industry | Healthcare, Marketing & Advertising |
| Parent Company / Owner | Petauri |
| Main Competitors | OPEN Health (76/100), Costello Medical (78/100), Evidera (PPD) (78/100), Lumanity, Avalere Health (86/100), ICON plc (84/100), PRMA Consulting |
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Specialist pharmaceutical and medtech market access, pricing and HEOR consultancy, with innovative digital solutions - Full Veeva Content Partner" (Meta description: 19 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, og:title, og:description, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost.
Social footprint: verified profiles on X (Twitter), YouTube, GitHub; no detected presence on LinkedIn, Facebook, Instagram - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked November 2026.
When asked "What is Mtech Access (Petauri Evidence)?", Claude could identify the brand as of November 2026. Mtech Access is a UK-based market access and health economics consultancy that helps pharmaceutical, biotech, and medtech companies with HTA submissions, value dossiers, pricing and reimbursement strategy, and health outcomes research; it was rebranded as Petauri Evidence after b Best known for Market access and health technology assessment (HTA) consulting for pharma and medtech companies.
When asked "Best brands similar to Mtech Access (Petauri Evidence)?", Claude would recommend Mtech Access (Petauri Evidence) as of November 2026. It's a recognized and established player in UK market access consulting, so it would be worth mentioning alongside similar HEOR and HTA-focused firms.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Mtech Access (Petauri Evidence)'s main competitors in Healthcare: OPEN Health (76/100), Costello Medical (78/100), Evidera (PPD) (78/100), Avalere Health (86/100), ICON plc (84/100).
Sources: Brand Analyzer scan
Mtech Access (Petauri Evidence) has low AI-search visibility, scoring 17/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 15, recommendation 48). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Mtech Access (Petauri Evidence) scores 48/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Mtech Access, part of Petauri Evidence, is a specialist consultancy providing market access, pricing, and health economics and outcomes research (HEOR) services to pharmaceutical, biotechnology, and medical device companies. It combines consultancy expertise with digital solutions and holds full Veeva Content Partner status to support clients in demonstrating product value for reimbursement and market access purposes.
Mtech Access (Petauri Evidence) can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Mtech Access offers market access consultancy, pricing strategy support, and health economics and outcomes research (HEOR) services. It also provides digital solutions for evidence generation and communication, along with Veeva-compliant content development and management as a full Veeva Content Partner, supporting clients across the full product lifecycle.
Mtech Access is used by market access, pricing, and HEOR teams within pharmaceutical, biotechnology, and medical device companies. These teams rely on the firm to generate and communicate evidence needed to demonstrate product value, support reimbursement decisions, and achieve market access milestones in global and local healthcare markets.
Mtech Access is known for its specialist expertise in pharmaceutical and medtech market access, pricing, and HEOR consultancy, combined with digital solutions. It is also recognized for holding full Veeva Content Partner status, which distinguishes it in the production and management of promotional and medical content materials for life sciences clients.
Mtech Access (Petauri Evidence) scores 17/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Mtech Access (Petauri Evidence) has a weak AI-visibility profile at 17/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (48/100) and its weakest is visibility (0/100). It benefits from open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and thin schema.org structured data. In a live check, Claude could already identify Mtech Access (Petauri Evidence) from memory (November 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.